New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics

Published:2018-06-27 Issue:2 Volume:33 Page:61-64
ISSN:2363-8915
Container-title:Drug Metabolism and Personalized Therapy
language:
Short-container-title:

Author:

Nair Sujit^ORCID,LLerena Adrián

Publisher

Walter de Gruyter GmbH

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.degruyter.com/document/doi/10.1515/dmpt-2018-0008/pdf

Reference50 articles.

1. PD-1 Blockers;Cell,2015

2. Pharmacometrics of nutraceutical sulforaphane and its implications in prostate cancer prevention;Journal of Chinese Pharmaceutical Sciences,2016

3. Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial;Cancer Lett,2018

4. Pharmacokinetics and systems pharmacology of monoclonal antibody olaratumab for inoperable soft tissue sarcoma;Adv Mod Oncol Res,2017

5. Pharmacogenomics in pain treatment;Drug Metab Pers Ther,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics and ethnicity: “Dr. José María Cantú” award announcement;Drug Metabolism and Personalized Therapy;2023-05-08

2. Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction;Translational Oncology;2022-11

3. Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery;Pharmaceuticals;2022-10-14

4. Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention;Critical Reviews in Food Science and Nutrition;2021-08-26

5. Current Translational Insights into MGMT Methylation Regulating Temozolomide Sensitivity and Resistance in Glioblastoma Multiforme;Current Pharmacogenomics and Personalized Medicine;2020-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3